Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | BCL201 + MIK665 |
| Synonyms | |
| Therapy Description | |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| BCL201 | S55746|S-55746|BCL-201|BCL 201 | BCL2 inhibitor 29 | BCL201 (S55746) inhibits BCL2, potentially resulting in increased tumor cell apoptosis (PMID: 29732004). | |
| MIK665 | MIK-665|MIK 665|S64315 | MCL1 Inhibitor 18 | MIK-665 (S64315) inhibits MCL1, potentially resulting in increased apoptosis of MCL-1 expressing tumor cells (PMID: 32513939). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|